-----

Welcome to the May 2011 issue of Pharmaceutical Technology Sourcing and Management, your information resource about the pharmaceutical supply chain. In this issue, an analysis of the slowing volume and revenue growth for the US prescription drug market and trends in third-party external supply networks. And the latest developments from the bio/pharmaceutical industry relating to corporate social responsibility and sustainability.

APIs
Growth in the US Prescription Drug Market Slows
Patricia Van Arnum, senior editor of Pharmaceutical Technology, and editor of Sourcing and Management
Volume growth in the US prescription drug market was at historically low levels in 2010, and revenue growth was anemic. >> Read More

Outsourcing
A Hard Look at Third-Party External Supply Networks
Gregg Brandyberry, CEO of Wildfire Commerce, senior advisor for A.T. Kearney Procurement and Analytic Solutions, and contributing editor to Pharmaceutical Technology
The complexity of third-party external supply networks requires new ways to manage them.
>> Read More

Pharma Partner Focus
Spectrum Chemical Expands in China
Patricia Van Arnum, senior editor of Pharmaceutical Technology, and editor of Sourcing and Management
Spectrum Chemical Mfg., a supplier of fine chemicals and pharmaceutical ingredients, opens new facilities in China and augments its custom-synthesis business.
>> Read More

Sourcing
Innovation in the Pharma Supply Chain
Patricia Van Arnum, senior editor of Pharmaceutical Technology, and editor of Sourcing and Management
The DCAT–ISM Sourcing Summit, to be held in July, will focus on innovative practices and strategies for optimizing sourcing, procurement, and the management of the pharmaceutical supply chain.
>> Read More

CSR and Sustainability Forum
Pharmaceutical Technology’s dedicated editorial coverage on the developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, other business sectors, and public and private organizations. This month, we feature articles on pharmaceutical distribution and administration models for the developing world, a partnership between GlaxoSmithKline and Singapore in green manufacturing, and a roundup of CSR and sustainability news.

Distribution and Administration in Public Health, Government, and Developing World Markets
Chan Harjivan and James Guyton, PRTM
This article, which focuses on distribution and administration, is Part III of a three-part series on biopharmaceutical issues in public health, government, and developing world markets. >> Read More

GlaxoSmithKline and Singapore Partner in Green Manufacturing
A Q&A moderated by Patricia Van Arnum, senior editor of Pharmaceutical Technology, and editor of Sourcing and Management
Eli Lilly and GlaxoSmithKline are among several pharmaceutical companies using technology transfer as a way to improve health outcomes in the developing world. >> Read More

CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations. >> Read More

-----

Sourcing and Management’s Community of Experts
The panel consists of leading professionals involved in the synthesis, manufacture, and sourcing of active pharmaceutical ingredients and intermediates, and experts in formulation and dosage-form manufacturing. The community of experts lends its expertise to the eNewsletter by providing reviews of technical articles as well as offering perspectives on topics of relevance to pharmaceutical manufacturers and their suppliers.
>> Read More

-----

For the full listing of calendar events, see the Calendar of Events page

May

May 16–18
AAPS National Biotechnology Conference
San Francisco

June

June 15–16
Chemspec Europe
Geneva, Switzerland